Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus routine dual antiplatelet therapy after EVT with tirofiban for presumed ICAS-related anterior circulation stroke
ChiCTR2600135618Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of aspirin, clopidogrel and tirofiban in brain infarction (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Proportion of favourable functional outcome, Proportion of symptomatic intracranial haemorrhage and 1 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
aspirinclopidogreltirofiban
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR2600135618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135618.